[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 91
Citations 0
In This Issue of JAMA Otolaryngology
July 2016


JAMA Otolaryngol Head Neck Surg. 2016;142(7):621. doi:10.1001/jamaoto.2015.1815

There is controversy regarding the etiological role of gastroesophageal reflux and the benefit of antireflux medications in chronic rhinosinusitis. Gilani et al used data from the 2005 to 2010 National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey to examine national prescribing patterns for antireflux medication in patients with chronic rhinosinusitis. They found that these patients were significantly less likely to receive proton pump inhibitors, histamine receptor antagonists, antacids, or prokinetic agents than those without chronic rhinosinusitis. National practice patterns do not support antireflux therapy for chronic rhinosinusitis. Bock and Poetker provide an Invited Commentary.

First Page Preview View Large
First page PDF preview
First page PDF preview